Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1349Erstellt: 23. Oktober 2026

Dimethylformamide → 1-(2'-Methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1h-1-benzazepine

https://huagongshe.com/de/reaction/1349

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktDimethylformamideHCID 6228—
EduktOxalyl chlorideHCID 65578—
Edukt1,2,3,4-Tetrahydro-benzo(b)azepin-5-oneHCID 294788—
Edukt2-Methoxy-[1,1'-biphenyl]-4-carboxylic acidHCID 17997392—
LösungsmittelWaterHCID 962—
LösungsmittelDichloromethaneHCID 6344—
LösungsmittelTriethylamineHCID 8471—
Produkt1-(2'-Methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1h-1-benzazepineHCID 54335813—

Reaktionsschritte

A 1.67 g portion of 2-methoxybiphen-4-ylcarboxylic acid was dissolved in 17 ml of dichloromethane, 0.95 ml of oxalyl chloride and a catalytically effective amount of dimethylformamide were added to the resulting solution with cooling on an ice bath and then the resulting mixture was warmed up to room temperature. When completion of foaming was confirmed, the reaction solution was concentrated under a reduced pressure and subjected to azeotropic treatment with toluene twice. The thus obtained residue was dissolved in 8.4 ml of dichloromethane and, with cooling on an ice bath, the resulting solution was dropwise added to a solution obtained by dissolving 1.0 g of 5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine and 1.53 ml of triethylamine in 10 ml of dichloromethane. The reaction solution was warmed up to room temperature and the stirring was continued for 1 hour. The resulting reaction solution was mixed with water and subjected to phase separation to separate dichloromethane layer which was subsequently washed with 0.5N hydrochloric acid and a saturated sodium bicarbonate aqueous solution and dried over anhydrous magnesium sulfate. After removing the solvent by distillation, the thus obtained residue was crystallized from toluene to obtain 1.65 g of 1-(2'-methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine as crude crystals.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS05723606
Quelldatensatzuspto-grants-1998_03
ORD IDord-3679fbd88dec487795772a47ae39b783
Quellennotizuspto-grants-1998_03